13F-HR/A filed by Sofinnova Investments, Inc.
Sofinnova Investments, Inc. filed this 13F-HR/A for the quarter ended 2018-12-31, filed 2019-02-22, with 59 holding rows worth $802,715,000.
- Accession
- 0001144204-19-009466
- Filer
- CIK 1631134
- Filed
- 2019-02-22
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2018
A holdings report, amendment of type restatement, 137 entries on the cover page, a total value of $802,715,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $802,715,000 with VALUE read as thousands by filing date, 13F file number 028-18774. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerCrestline Management, LP028-14917
- included managerBlackstone Alternative Asset Management L.P.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 1,498,538 | $93,883,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 5,208,305 | $70,885,000 | thousands by filing date | |
| ObsEva SA | H5861P103 | COM | 4,749,623 | $60,130,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 2,038,208 | $55,827,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 3,100,560 | $43,284,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 2,104,278 | $42,801,000 | thousands by filing date | |
| Nucana PLC | GB00BYWYV | COMMON SHARES | 2,400,000 | $34,800,000 | thousands by filing date | |
| NUCANA PLC | 67022C106 | ADR | 2,266,666 | $32,867,000 | thousands by filing date | |
| MERUS N V | N5749R100 | COM | 1,961,039 | $27,455,000 | thousands by filing date | |
| COHERUS ONCOLOGY INC | 19249H103 | COM | 2,868,221 | $25,957,000 | thousands by filing date | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 922,700 | $25,919,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 933,640 | $19,905,000 | thousands by filing date | |
| SPARK THERAPEUTICS INC | 84652J103 | COM | 481,270 | $18,837,000 | thousands by filing date | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 327,175 | $14,203,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,911,573 | $14,127,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 213,331 | $13,343,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 316,328 | $12,015,000 | thousands by filing date | |
| INCYTE CORP COM | 45337C102 | Stock | 188,497 | $11,987,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 140,542 | $11,968,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 134,297 | $9,971,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 359,713 | $9,331,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 157,984 | $8,863,000 | thousands by filing date | |
| ITERUM THERAPEUTICS PLC SHS NEW | G6333L101 | Stock | 1,726,514 | $8,650,000 | thousands by filing date | |
| Morphosys | D55040105 | COM | 80,536 | $8,217,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 3,382,174 | $7,778,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 199,682 | $7,221,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 674,636 | $6,462,000 | thousands by filing date | |
| SAVARA INC | 805111101 | COM | 754,372 | $5,711,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 265,475 | $5,572,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 54,472 | $5,491,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 48,894 | $5,337,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 287,769 | $5,168,000 | thousands by filing date | |
| CHIASMA INC | 16706W102 | COM | 1,630,221 | $5,070,000 | thousands by filing date | |
| ENTASIS THERAPEUTICS HLDGS I | 293614103 | COM | 1,180,178 | $4,803,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 61,500 | $4,393,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 332,921 | $4,228,000 | thousands by filing date | |
| AIMMUNE THERAPEUTICS INC. | 00900T107 | Common Stock | 175,775 | $4,205,000 | thousands by filing date | |
| SYNLOGIC INC | 87166L100 | COM | 574,972 | $4,031,000 | thousands by filing date | |
| DERMIRA INC | 24983L104 | COM | 542,224 | $3,899,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 190,627 | $3,879,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 80,000 | $3,702,000 | thousands by filing date | |
| BIOHAVEN PHARMACEUTICAL HOLDIN | G11196105 | COM | 97,445 | $3,604,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 222,618 | $3,502,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 563,655 | $3,472,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 1,651,172 | $3,435,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 832,293 | $2,987,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 229,813 | $2,948,000 | thousands by filing date | |
| FIVE PRIME THERAPEUTICS INC. | 33830X104 | Common Stock | 315,344 | $2,933,000 | thousands by filing date | |
| GW PHARMACEUTICALS PLC | 36197T103 | ADS | 30,000 | $2,922,000 | thousands by filing date | |
| KALA BIO INC COM | 483119103 | Stock | 445,516 | $2,178,000 | thousands by filing date | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 447,075 | $2,146,000 | thousands by filing date | |
| RVL PHARMACEUTICALS PLC | G6S41R101 | COM | 253,089 | $1,961,000 | thousands by filing date | |
| OTONOMY INC | 68906L105 | COM | 1,023,865 | $1,894,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 25,020 | $1,595,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 350,110 | $1,558,000 | thousands by filing date | |
| CONATUS PHARMACEUTICALS INC | 20600T108 | COM | 638,197 | $1,104,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 2,852,711 | $916,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 16,994 | $731,000 | thousands by filing date | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 49,580 | $654,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-19-007829 | superseded | 2019-02-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001144204-19-009466 | this filing | 2019-02-22 | acceptance time not in the bulk data set |